Search PDMR transactions

Notifier
Name of person with notification obligation
Dag Andersson Tilk
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Dag Andersson Tilk
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
No
Amendment
Yes
Details of amendment
Lösen minskning lösen ökning
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xvivo Perfusion Aktiebolag
Issuer´s LEI code
549300G2464FYLS14B41
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant XVIVO 2020/2022 Disposal 26,583 Quantity 41.95 SEK 24/05/2022 Outside a trading venue
Subcription warrant XVIVO 2020/2022 Exercise decrease 5,417 Quantity 0.00 SEK 24/05/2022 Outside a trading venue
Share Xvivo Perfusion AB SE0004840718 Exercise increase 5,417 Quantity 205.88 SEK 24/05/2022 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
XVIVO 2020/2022 Disposal 24/05/2022 Outside a trading venue 26,583 (Quantity) 41.95 SEK
XVIVO 2020/2022 Exercise decrease 24/05/2022 Outside a trading venue 5,417 (Quantity) 0.00 SEK
Xvivo Perfusion AB SE0004840718 Exercise increase 24/05/2022 Outside a trading venue 5,417 (Quantity) 205.88 SEK
<< Back